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A  functional  division within  the immune response  has  become generally accepted 
in  recent  years.  Functions  associated  with  cell-mediated immunity  are  mainly  de- 
pendent upon the thymus-influenced (T) lymphocyte (1, 2), whereas antibody produc- 
tion  is  generally  dependent  upon  the  non-thymus-influenced  (B)  lymphocyte  (3). 
However, there is considerable evidence that,  for at least some antigens,  T  cells also 
participate  in  the  antibody  response  (4,  5).  A  considerable  body  of  knowledge  re- 
garding  the nature  and  function of the  two cell types has  accumulated,  but little is 
known  concerning their relative specificities. Several reports  have dealt with cellular 
cross-reactions  between  antigens  which  exhibit  little or no  humoral  cross-reactivity 
(6-8),  a  phenomenon  which  suggests  differences  in  the  specificities  of  the  two  cell 
types. A report from this laboratory (9)  demonstrated a similar phenomenon with egg 
white  lysozyme  and  its  reduced  and  carboxymethylated  derivative,  CM-lysozyme. 
These  two  forms  of lysozyme,  which  are  well  documented  to  be  non-cross-reactive 
at the humoral level (9-11) were shown to cross-react with respect to several parame- 
ters  of  the  immune  response,  namely  delayed  skin  reactivity,  migration-inhibitory 
factor  production,  stimulation  of  splenic  lymphocytes,  and  cyclophosphamide-in- 
duced  tolerance.  The  experiments  presented  herein  demonstrate  that  this  cross- 
reactivity extends  to  neonatally  and  adult-induced  tolerance. 
Materials and Methods 
Antigens.--Hen  egg white  lysozyme  (Muramidase),  3X  crystallized and  salt free,  was 
purchased from Miles Laboratories, Inc., Elkhart, Ind. Reduction and alkylation of lysozyme 
was carried out according to the method of Canfield and Anfinsen (12). 
Animals.  Mice of the BAB/14 strain were used  throughout. 
Tolerance Induction.--Neonatal  mice received one  of  the following subcutaneous  treat- 
ments  with  lysozyme in  saline,  commencing on  the  1st  day  of life:  100 #g  on  days  1-20; 
500/~g on  day 1;  1 mg on days  1-20; 5 mg on day 1; 5 mg on days 1-2; and  5 mg on days 
1-4.  All neonatally  treated  mice received primary  challenge at  6  wk  of  age.  Tolerance in 
adult animals (6-8-wk old) was induced by intraperitoneal administration of 50 mg of lysozyme 
in 0.5 ml of saline; primary challenge was given I0 days later. 
Immunization.  All  animals  were  challenged  with  100  #g  of  either  lysozyme  or  CM- 
* Supported in part by U.S. Public Health Service Grant AM-15174  and National Science 
Foundation  Grant  GB-30697. 
:~ Recipient of a postdoctoral fellowship (1-F02-AM35714)  from the National Institutes of 
Health. 
1308  THE  JOURNAL  OF  EXPERIMENTAI.  MEDICINE  - VOLUME 136, 1972 SCIBIENSKI ET  AL.  BRIEF  DEFINITIVE REPORT  1309 
lysozyme  in  0.2  ml  of  complete  Freund's  adjuvant  (Mycobacterium  tuberculosis  H37Ra; 
Difco Labs.,  Inc., Detroit,  Mich.)  administered  to all four footpads  and  intraperitoneally. 
This was followed 2 wk later with 100 #g of antigen and 100 #g of Benadryl (Parke, Davis & 
Company, Detroit, Mich.)  in 0.1  ml of saline administered intraperitoneally. All mice were 
bled from the tail vein 2 wk after the secondary challenge, the time previously established to 
be the peak of the normal response elicited by this immunization schedule. 
Antibody  Assay.--Individual  sera were diluted  1/10,  1/100,  and  1/1000  in borate  (0.05 
~)-buffered saline (BBS), pH 8.0.  The two higher dilutions were supplemented with normal 
mouse serum to equalize the protein concentration. A mixture of 0.1 ml of each serum dilution 
and 0.1 ml of a 1.0 #g/ml solution of antigen-l~I in 0.1 •  NaHCO3 was incubated for 30 rain 
at  room  temperature  and  precipitated  by  an  excess  of hyperimmune  rabbit  antiserum  to 
mouse globulins. The tubes were counted  in a  Nuclear-Chicago automatic gamma counter 
(Nuclear-Chicago Corp., Des Plaines, Ill.) before centrifugation and after centrifugation and 
two washes with BBS. The per cent of antigen bound was calculated according to the formula: 
X  --  (Y  --  X)K 
where X  represents counts precipitated,  Y represents total  counts added, 
Y 
and  K  represents  that  fraction  of the antigen precipitated  by normal mouse serum under 
comparable  conditions  (i.e.,  background). 
The antigen-binding capacity (ABC-33)  was determined  by plotting the per cent antigen 
bound on a linear scale vs. serum dilution on a log scale.  From the resulting line, that dilution 
of antiserum which bound 33%  (0.033 #g) of the antigen was determined, and a direct con- 
version was made to the micrograms of antigen bound  by  1 ml of undiluted antiserum.  In 
some cases the binding was too low to assess  the 33% point even by extrapolation. In these 
cases the ABC was calculated directly from the 1/10 dilution. 
Iodination.--Iodination  of lysozyme and  CM-lysozyme was according to  the method of 
McConahey and Dixon (13).  Unbound iodine was removed by passing the reaction mixtures 
through 1 X  40 cm columns of Sephadex G-25  (Pharmacia Fine Chemicals, Inc., Piscataway, 
N. J.)  equilibrated with 0.1  M NaHCO3. 
RESULTS 
The responses  to lysozyme or to CM-lysozyme of animals which had under- 
gone various tolerization  regimens with lysozyme are shown in Table  I. When 
compared  with the response  of normal  animals,  all treatments  except one  (100 
/~g  for  20  days)  resulted  in  either  severe  suppression  or  outright  abolition  of 
the  antibody  response  to  lysozyme.  Moreover,  animals  which  had  undergone 
identical  treatments  with  lysozyme  were  also  tolerant  to  CM-lysozyme.  In 
contrast  (data not shown),  mice given 20 mg of bovine selum albumin over the 
first 4  days  of life responded  normally to both lysozyme and  to CM-lysozyme, 
and  lysozyme-tolerant  animals  (as  in  group  D,  Table  I)  responded  to  a  non- 
related  antigen,  tobacco mosaic virus protein,  in a  normal  manner. 
DISCUSSION 
There are several reports which indicate that immunological cross-reactivity 
at  the  level of delayed hypersensitivity  may exist between  antigens  which  are 
not necessarily  cross-reactive  at  the humoral  level  (6-8).  In  a  previous report 
from  this  laboratory  (9),  evidence  was  presented  for  immunological  cross- 
reaction  between lysozyme and  CM-lysozyme as assessed  by several measures 
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tive. The present communication offers evidence for cross-reaction with respect 
to  still  another  immunological  parameter,  namely,  the  existence  of  cross- 
tolerance between these two antigens? 
Delayed  hypersensitivity  is  now  generally  accepted  as  being  a  function  of 
the thymus-influenced  (T) lymphocyte  (1, 2). The lack of humoral  (B lympho- 
cyte) cross-reactivity in the present system suggests that T  cells are responsible 
for  the  cross-reactions  observed  with  respect  to  the  other  parameters  which 
we  have  reported  (9).  Consequently,  if  tolerance  is  operative  at  the  level  of 
both  T  and  B  cells,  it would  be  expected  that  tolerization  to  lysozyme would 
also  render  the  animals  tolerant  to  CM-lysozyme  by  virtue  of  their  cross- 
reactivity at the T  cell level. The data presented in this communication support 
TABLE I 
Cross-Tolerance  between Lysozyme and C)l/[-Lysozyme 
Group  Treatment* 
Response  to lysozyme  Response  to CM-lysozyme 
Responders~  Titer  Responders~  Titer 
A  None  11/11  (i6.4 4- 5.3)  9/9  (4.3 ::= 2.4) 
13  109 ~g/20 days  4/4  (6.4 =t= 2.6)  N.D.§ 
C  500 ~g/1 day  2/6  (2.4 4- 2.1)  0/4  0 
D  1 mg/20 days  3/10  (0.5 ::t= 0.3)  0/11  0 
E  5 mg/1 day  2/9  (0.85 4- 0.5)  0/3  0 
F  5 mg/2 days  4/13  (0.36 4- 0.43)  0/6  0 
G  5 mg/4 days  2/6  (0.12 4- 0.01)  0/6  0 
H  50 mg/1 day[[  6/6  (1.7 =1= 1.5)  I/6  (1.1) 
* Amount of lysozyme  given  per day/No, of days administered, commencing  on 1st day of life. 
,+ No. of responders/No, challenged.  Titer is ABC-33 (mean  4- sD) of responders only. 
§ Not done. 
[[ Adult-induced  tolerance,  6-8-wk  old animals  given  50 mg of lysozyme. 
this  hypothesis.  Furthermore,  this  view  is  consistent  with  the  finding  that 
mice  rendered  tolerant  by  the  lower tolerogen  doses  employed  here  produced 
antibodies  to  lysozyme  when  challenged  with  a  conjugate  of  lysozyme  and  a 
nonrelated  protein, 2 suggesting  that  only the helper  (T)  cell activity has  been 
eliminated  from  the  tolerant  animals.  T  cells are  thus  capable  of  recognizing 
similarities  between  two  antigens  which  are  totally  segregated  at  the  B  cell 
level.  Moreover,  in  view  of  the  extent  of  the  cross-tolerance,  the  tolerogen 
(lysozyme)  must  have  affected  a  majority,  if not the total,  of the T  cells cap- 
able  of  recognizing  CM-lysozyme? 
x Some years ago Austin and Nossal observed a cross-tolerant state between several sero- 
logically non-cross-reacting flagella from Salmonella sp.  (14). The cross-reactivity of  these 
flagella with respect to other immunological parameters was not investigated. 
2 R. Scibienski,  S. Fong, M. Harris, and E. Benjamini. Manuscript in preparation. 
It is unlikely that  the CM-lysozyme tolerance observed is the result of contamination 
of  the  tolerogen with  denatured  forms.  Inhibition  studies  revealed the  maximal degree of 
denaturation  of  the  tolerogen  to  be  less  than  0.1%  (R.  Scibienski,  unpublished  results), 
whereas  10/% of  a  tolerance-inducing  dose  had  only a  minimal suppressive  effect on  the 
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T  cell  cross-reactivity in the  absence of B  cell  cross-reactivity implies  that 
there  are  basic  differences  either  in  the  antigenic  specificity  of  the  two  cell 
types or in their activation requirements.  Consistent with one or both of these 
ideas  are  the  findings  that  T  cell-associated  genetic  control  of  immune  re- 
sponsiveness  is  not linked  to  any of the known immunoglobulin  allotypes  in 
the mouse (15), the paucity (16), if not the absence (17, 18), of immunoglobulin 
on the surface of T  cells,  and the exquisite  sensitivity of T  cells to antigen  as 
compared with  B  cells  (19).  The basis  of these  differences is not known,  but 
the  present  results  suggest  that  T  cells  may be  less  dependent  on conforma- 
tional features than are B  cells. 
REFERENCES 
1.  Miller,  J. F. A. P., A. H. E. Marshall, and R. J. White. 1962. The immunological 
significance  of the thymus. Adv. Immunol.  2:111. 
2.  Good, R. A., A. P. Dalmasso, C. Martinez, O. K. Archer, J. C. Pierce, and B. W. 
Papermaster.  1962.  The role  of the  thymus  in  development  of immunologic 
capacity in rabbits and mice. J. Exp. Med. 116:773. 
3.  Mitchell,  G. F.,  and J.  F. A. P. Miller.  1968. Cell to cell  interaction in the im- 
mune  response.  II. The source of hemolysin-forming cells  in irradiated  mice 
given bone marrow and thymus or thoracic  duct lymphocytes. J. Exp. Med. 
128:821. 
4.  Miller,  J.  F. A. P.,  A. Basten,  J.  Sprent,  and C.  Cheers.  1971. Interactions be- 
tween lymphocytes in the immune response. Cell. lmmunol. 2:469. 
5.  Claman,  H. N.,  and E.  A. Chaperon.  1969. Immunologic complementation be- 
tween thymus and marrow cells.  A model for the two cell  theory of immuno- 
competence. Transplant.  Rev. 1:92. 
6.  Gell, P. G. H., and B. Benacerraf. 1959. Studies on hypersensitivity. II. Delayed 
hypersensitivity to denatured proteins  in guinea pigs. Immunology.  2:64. 
7.  Parkhouse, R. M. E., and R. W. Dutton. 1967. The effect of physical and chemi- 
cal modifications of antigens in the secondary response in vitro. Immunochem- 
istry. 4:431. 
8.  Parish,  C. R.  1971. Immune response  to chemically modified flagellin.  II. Evi- 
dence for a  fundamental relationship  between humoral and cell-mediated im- 
munity. J. Exp. Med. 134:21. 
9.  Thompson,  K.,  M.  Harris,  E.  Benjamini,  G.  F.  Mitchell,  and M.  Noble.  1972. 
Cellular  and  humoral  immunity: a  distinction  in antigenic  recognition.  Nat. 
New Biol. 238:20. 
10.  Gerwing, J., and K. Thompson. 1968. Studies on the antigenic recognition of egg 
white lysozyme. I. Isolation and characteristics  of a  tryptic peptide  from re- 
duced  and  alkylated  lysozyme  exhibiting  haptenic  activity.  Biochemistry. 
7:3888. 
11.  Young, J. D., and C. ¥. Leung. 1970. Immunochemical studies on lysozyme and 
CM-lysozyme. Biochemistry. 9:2755. 
12.  Canfield,  R. E., and C. B. Anfinsen. 1963. Chromatography of pepsin and chymo- 
trypsin  digests  of  egg  white  lysozyme on  phosphocellulose.  J.  Biol.  Chem. 
238:2684. 1312  SCIBIENSKI  ET  AL.  BRIEF  DEFINITIVE  REPORT 
13.  McConahey, P. J., and F. J. Dixon. 1966. A method for trace iodination of pro- 
teins for immunologic studies. Int. Arch.  Allergy  Appl. Immunol. 29:185. 
14.  Austin,  C. M.,  and G. J. V. Nossal.  1966. Mechanism of induction of  immuno- 
logical tolerance. III. Cross-tolerance amongst flagellar  antigens. Aust. J. Exp. 
Biol. M'ed. Sci. 44:341. 
15.  McDevitt, H. O., K. B. Bechtol, F. C. Grumet,  G. F. Mitchell, and T. G. Weg- 
man.  1971. Genetic  control  of  the  immune  response  to  branched  synthetic 
polypeptide antigens in inbred mice. In Progress in Immunology, Proceedings 
of  the  First  International  Congress  of Immunology. Bernard  Amos,  editor. 
Academic Press, New York. 
16.  Hammerling,  U.,  and  K.  Rajewsky.  1971.  Evidence  for  surface-associated  im- 
munoglobuli~ on T  and B lymphocytes. Eur. J. Immunol. 1:447. 
17.  Unanue, E. R., H. M. Grey, E. Rabellino, R. Campbell, and S. Schmidtke. 1971. 
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the 
main  source  of lymphocytes with  detectable  surface-bound immunoglobulin. 
J. Exp. Med. 133:1188. 
18.  Takahashi, T., L. J. Old, K. R. Mclntire, and E. A. Boyse. 1971. Immunoglobulin 
and other surface antigens of cells of the immune system. J. Exp. Ivied. 134:815. 
19.  Mitchison, N. A. 1971. The relative ability of T and B lymphocytes to see protein 
antigen. In Cell  Interactions and Receptor Antibodies in Immune Responses, 
Proceedings  of  the  Third  Sigrid  Juselius  Symposium.  O.  M~kel~i, A.  Cross, 
and T. U. Kosunen, editors. Academic Press, New York. 